Oxford Financial Group LTD Abiomed Inc Transaction History

Oxford Financial Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$242.49 - $301.46 $361,310 - $449,175	1,490 Added 24.39%	7,599 $1.87 Million
Q2 2022 Aug 11, 2022	BUY	$224.73 - $338.64 $1.04 Million - $1.57 Million	4,645 Added 317.28%	6,109 $1.51 Million
Q4 2021 Feb 10, 2022	BUY	$300.63 - $371.35 $4,208 - $5,198	14 Added 0.97%	1,464 $526,000
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $2.1 Million - $2.54 Million	-6,760 Reduced 82.34%	1,450 $472,000
Q1 2021 May 10, 2021	SELL	$285.92 - $355.13 $4,002 - $4,971	-14 Reduced 0.17%	8,210 $2.62 Million
Q4 2020 Feb 10, 2021	BUY	$251.88 - $324.2 $3,526 - $4,538	14 Added 0.17%	8,224 $2.67 Million
Q3 2020 Nov 12, 2020	BUY	$255.22 - $317.0 $2.1 Million - $2.6 Million	8,210 New	8,210 $2.28 Million

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Oxford Financial Group LTD, based on Form 13F filings with the SEC.

Stay updated on Oxford Financial Group LTD with notifications on news.